GlassScriptPhysician profile
David V Cossman
NPI 1639199896
$730.47
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $177 · 2021: $202 · 2022: $141 · 2024: $24.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $116.80 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $86.49 | 2021 | |
| Boston Scientific Corporation | $75.03 | 2021-2022 | |
| Getinge USA Sales, LLC | $74.42 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $65.01 | 2019-2021 | |
| Silk Road Medical, INC. | $48.81 | 2020-2021 | |
| Lemaitre Vascular, INC. | $37.06 | 2019 | |
| Medtronic Vascular, INC. | $33.78 | 2019-2020 | |
| Ethicon US, LLC | $30.78 | 2022 | |
| Bsn Medical INC | $28.16 | 2019-2022 | |
| Abbott Laboratories | $24.87 | 2024 | Perclose Prostyle |
| Terumo Medical Corporation | $23.63 | 2021 | |
| Avinger INC. | $22.74 | 2019 | |
| Cardiva Medical, INC. | $18.11 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.96 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.50 | 2022 | |
| Cardiovascular Systems INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.